GovChime
AWARDDELIVERY ORDEROther than small business

Delivery order 75N91022F00010LEIDOS BIOMEDICAL RESEARCH INC

Overview

Award facts

Net obligations
$16.87M
$16,869,382of $16.87M potential value
Outlays (paid to date)
$3.51M
$3.51M paid of $16.87M obligated$3,512,950
Period of performance
Jul 27, 2022 to Jul 26, 2027
Ends in 8 months
Modifications
6
Latest action Jun 3, 2026
Contract type
Delivery order
PIID 75N91022F00010

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

IND-DIRECTED DEVELOPMENT OF ANTIVIRAL THERAPIES TO COMBAT DISEASES OF PANDEMIC POTENTIAL

Dates and value

Award date
Signed on Jul 26, 2022
Current value
$16,869,382Base and exercised options
Potential value (if all options are exercised)
$16,869,382
Parent contract vehicle
75N91019D00024 (IDC, single award) — 185 orders recorded under it

Obligations by fiscal year of action

  • FY2026: -$1,843,960 (de-obligation)
  • FY2022: $18,713,342

Total across 2 fiscal years: $16,869,382

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 3, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationFREDERICK, MD
UEIHV8BH9BPG8Y9
CAGE code3LYK6
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyLEIDOS HOLDINGS, INC.

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NCATS
Funded from
Public health and social services emergency fundProgram activities075-0140, 075-0849, 075-0875, 075-0885, 075-3966Federal accounts (agency financial reports)

Place of performance

Place of performance
Frederick, Maryland 21703-2817
Congressional district (place of performance)
MD-06As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
Not reported
Contract pricing
Cost plus fixed feeU

Contract details

Subcontracting plan
Individual subcontract planF
Certified cost or pricing data
Yes
Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Jul 26, 2022Base obligation at award: $15,336,338
Latest action
Jun 3, 2026 — Other administrative actionModification P00006; administrative: no change in scope or value
Actions by type
  • Base award1
  • Other administrative action6
7 actions recorded, Jul 26, 2022 to Jun 3, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
Environmentally preferableF
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Delivery orderC
Parent vehicle type
IDCB
Parent vehicle: multiple or single award
Single awardS
Parent vehicle agency
National Institutes Of Health7529
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N910
Transactions recorded under this award key
7

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N95C
Treasury accounts
  • 075-2021/2021-0849-000
  • 075-2022/2022-0849-000
  • 075-2022/2022-0885-000
  • 075-2023/2023-0885-000
  • 075-2023/2025-3966-000
  • 075-2024/2024-0849-000
Show all 11 accounts
  • 075-2024/2024-0885-000
  • 075-2025/2025-0849-000
  • 075-2025/2025-0875-000
  • 075-2025/2025-0885-000
  • 075-X-0140-000
Object classes
  • 25.1: Advisory and assistance services
  • 25.2: Other services from non-Federal sources
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
  • V: Non-emergency P.L. 117-2
COVID-19 supplemental obligations
$16,869,382
COVID-19 supplemental outlays
$3,512,950